Ingredient Library
Ingredient context, clearly explained.
Reference articles on clascoterone terminology, how it compares with other approaches, and what the published literature does and does not say.
- Pillars1 min read
CB-03-01: What Is It and Is It the Same as Clascoterone?
CB-03-01, cortexolone 17α-propionate and clascoterone all refer to the same molecule at different stages of its life. Here is the naming map.
March 9, 2026Read - Comparisons1 min read
Clascoterone vs RU58841: Mechanism, Evidence and Key Differences
RU58841 is frequently discussed online as a topical anti-androgen. The mechanism is similar to clascoterone's; the evidence base and regulatory status are not.
March 2, 2026Read - Formulation Guide1 min read
Clascoterone Cream vs Solution: What's the Difference?
Same molecule, two very different delivery systems. The vehicle determines where the active goes and how it feels.
February 23, 2026Read - Clinical Trials2 min read
Clascoterone Hair Loss Results: Phase III Data Explained
Hair count endpoints, vehicle controls and dose response — how to read clascoterone's trial results without overstating them.
February 16, 2026Read - Clinical Trials2 min read
Clascoterone Side Effects: What Clinical Studies Show
Topical clascoterone has been studied in more than 1,440 patients in Phase III. Here is what the safety data actually reported — and what remains unknown.
February 9, 2026Read - Comparisons1 min read
Clascoterone vs Finas***: A Detailed Comparison
One works systemically upstream of DHT production, the other locally at the receptor. The difference explains almost everything about their respective safety conversations.
February 2, 2026Read - Formulation Guide2 min read
Clascoterone 5% Topical Solution: What You Need to Know
The 5% concentration is the most frequently referenced strength in clascoterone scalp research. Here is what the concentration means in practice.
January 24, 2026Read - Comparisons2 min read
Clascoterone vs Minox***: Which Mechanism Is Different and Why?
These two topicals are often framed as competitors. They are not: one addresses the cause of miniaturisation, the other extends the growth phase. Here is the mechanistic difference in full.
January 18, 2026Read - Pillars3 min read
Clascoterone for Hair Loss: The Complete Guide
Clascoterone is the first topical androgen receptor antagonist studied for androgenetic alopecia. Here is what the science actually shows — mechanism, trial data, dosing and realistic expectations.
January 12, 2026Read